» Articles » PMID: 33542154

Pluripotent Stem Cell-derived Epithelium Misidentified As Brain Microvascular Endothelium Requires ETS Factors to Acquire Vascular Fate

Abstract

Cells derived from pluripotent sources in vitro must resemble those found in vivo as closely as possible at both transcriptional and functional levels in order to be a useful tool for studying diseases and developing therapeutics. Recently, differentiation of human pluripotent stem cells (hPSCs) into brain microvascular endothelial cells (ECs) with blood-brain barrier (BBB)-like properties has been reported. These cells have since been used as a robust in vitro BBB model for drug delivery and mechanistic understanding of neurological diseases. However, the precise cellular identity of these induced brain microvascular endothelial cells (iBMECs) has not been well described. Employing a comprehensive transcriptomic metaanalysis of previously published hPSC-derived cells validated by physiological assays, we demonstrate that iBMECs lack functional attributes of ECs since they are deficient in vascular lineage genes while expressing clusters of genes related to the neuroectodermal epithelial lineage (Epi-iBMEC). Overexpression of key endothelial ETS transcription factors (, , and ) reprograms Epi-iBMECs into authentic endothelial cells that are congruent with bona fide endothelium at both transcriptomic as well as some functional levels. This approach could eventually be used to develop a robust human BBB model in vitro that resembles the human brain EC in vivo for functional studies and drug discovery.

Citing Articles

Transcriptional Responses of In Vitro Blood-Brain Barrier Models to Shear Stress.

Foreman K, Gastfriend B, Katt M, Palecek S, Shusta E Biomolecules. 2025; 15(2).

PMID: 40001496 PMC: 11853657. DOI: 10.3390/biom15020193.


Old World alphaviruses use distinct mechanisms to infect brain microvascular endothelial cells for neuroinvasion.

Alvarez P, Tang A, Winters D, Kaushal P, Medina A, Kaczor-Urbanowicz K bioRxiv. 2025; .

PMID: 39896450 PMC: 11785202. DOI: 10.1101/2025.01.22.634395.


The Rise of Pluripotent Stem Cell-Derived Glia Models of Neuroinflammation.

Kala S, Strutz A, Katt M Neurol Int. 2025; 17(1).

PMID: 39852770 PMC: 11767680. DOI: 10.3390/neurolint17010006.


Glutamine metabolism is systemically different between primary and induced pluripotent stem cell-derived brain microvascular endothelial cells.

Weber C, Moiz B, Kheradmand M, Scott A, Kettula C, Wunderler B J Cereb Blood Flow Metab. 2025; 271678X241310729.

PMID: 39763385 PMC: 11705297. DOI: 10.1177/0271678X241310729.


LRRK2 G2019S Mutated iPSC-Derived Endothelial Cells Exhibit Increased α-Synuclein, Mitochondrial Impairment, and Altered Inflammatory Responses.

Sonninen T, Peltonen S, Niskanen J, Hamalainen R, Koistinaho J, Lehtonen S Int J Mol Sci. 2024; 25(23).

PMID: 39684585 PMC: 11641647. DOI: 10.3390/ijms252312874.


References
1.
Sances S, Ho R, Vatine G, West D, Laperle A, Meyer A . Human iPSC-Derived Endothelial Cells and Microengineered Organ-Chip Enhance Neuronal Development. Stem Cell Reports. 2018; 10(4):1222-1236. PMC: 5998748. DOI: 10.1016/j.stemcr.2018.02.012. View

2.
Yoder M . Differentiation of pluripotent stem cells into endothelial cells. Curr Opin Hematol. 2015; 22(3):252-7. PMC: 4429532. DOI: 10.1097/MOH.0000000000000140. View

3.
Keep R, Jones H, Drewes L . The year in review: progress in brain barriers and brain fluid research in 2018. Fluids Barriers CNS. 2019; 16(1):4. PMC: 6362595. DOI: 10.1186/s12987-019-0124-y. View

4.
Lippmann E, Al-Ahmad A, Palecek S, Shusta E . Modeling the blood-brain barrier using stem cell sources. Fluids Barriers CNS. 2013; 10(1):2. PMC: 3564868. DOI: 10.1186/2045-8118-10-2. View

5.
Dimitroff C, Lee J, Rafii S, Fuhlbrigge R, Sackstein R . CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J Cell Biol. 2001; 153(6):1277-86. PMC: 2192031. DOI: 10.1083/jcb.153.6.1277. View